Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
afamelanotide | melanocyte-stimulating hormone receptor | small molecule | NA | drugbank , DGIDB | Dermatitis Phototoxic[MeSHID:D017484] Erythropoietic Protoporphyria[MeSHID:D046351] Porphyria Erythropoietic[MeSHID:D017092] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Vitiligo[MeSHID:D014820] |
18.56 | approved,investigational | agonist |
afamelanotide | melanocortin receptor 1 | NA | Successful target | TTD , DGIDB | Dermatitis Phototoxic[MeSHID:D017484] Erythropoietic Protoporphyria[MeSHID:D046351] Porphyria Erythropoietic[MeSHID:D017092] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Vitiligo[MeSHID:D014820] |
18.56 | approved | unknown |
afamelanotide | melanocortin receptor 1 | NA | Successful target | TTD , DGIDB | Dermatitis Phototoxic[MeSHID:D017484] Erythropoietic Protoporphyria[MeSHID:D046351] Porphyria Erythropoietic[MeSHID:D017092] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Vitiligo[MeSHID:D014820] |
18.56 | approved | agonist |
click here to return to the previous page |